WILMINGTON – Pharmaceutical giant AstraZeneca has signed two separate global development and commercialization agreements for drugs that treat a protein disease, signaling that the firm sees the patient segment as […]
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.